Preparation of novel curdlan nanoparticles for intracellular siRNA delivery

Carbohydrate Polymers

Volumn 117, Issue , 2015, Pages 324-330

  Han, Jingfen ^a   Cai, Jia ^a   Borjihan, Wuyinga ^a   Ganbold, Tsogzolmaa ^a   Rana, Tariq M ^b,c   Baigude, Huricha ^a,b  

^a INNER MONGOLIA UNIVERSITY   (China)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cancer cells; Curdlan; Nanoparticles; RT qPCR; siRNA delivery

Indexed keywords

BIOCOMPATIBILITY; CYTOLOGY; DISEASES; FOOD ADDITIVES; GENE EXPRESSION; NANOPARTICLES; NUCLEIC ACIDS; POLYMERASE CHAIN REACTION; PROTEINS;

CANCER CELLS; CHEMICALLY MODIFIED; CLINICAL APPLICATION; CURDLAN; HUMAN CANCER CELLS; MOLECULAR APPROACH; RT-QPCR; SIRNA DELIVERY;

RNA;

BETA GLUCAN; CURDLAN; DRUG CARRIER; NANOPARTICLE; SMALL INTERFERING RNA;

ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EMBRYONIC STEM CELL; GENETICS; HCT116 CELL LINE; HELA CELL LINE; HUMAN; METABOLISM; MOUSE; RNA INTERFERENCE;

ANIMALS; BETA-GLUCANS; CELL SURVIVAL; CELLS, CULTURED; DRUG CARRIERS; EMBRYONIC STEM CELLS; HCT116 CELLS; HELA CELLS; HUMANS; MICE; NANOPARTICLES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84922311558     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.09.069     Document Type: Article

References (28)

1. A. Akinc, W. Querbes, S. De, J. Qin, M. Frank-Kamenetsky, and K.N. Jayaprakash Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms Molecular Therapy 18 7 2010 1357 1364
2. M. Aouadi, G.J. Tesz, S.M. Nicoloro, M. Wang, M. Chouinard, and E. Soto Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation Nature 458 7242 2009 1180 1184
3. G. Borjihan, G. Zhong, H. Baigude, H. Nakashima, and T. Uryu Synthesis and anti-HIV activity of 6-amino-6-deoxy-(1→3)-β-d-curdlan sulfate Polymers for Advanced Technologies 14 2003 326 329
4. Y.L. Chiu, and T.M. Rana RNAi in human cells: Basic structural and functional features of small interfering RNA Molecular Cell 10 3 2002 549 561
5. Y.L. Chiu, and T.M. Rana siRNA function in RNAi: A chemical modification analysis RNA 9 9 2003 1034 1048
6. M.E. Davis, J.E. Zuckerman, C.H. Choi, D. Seligson, A. Tolcher, and C.A. Alabi Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 7291 2010 1067 1070
7. A. Detzer, M. Overhoff, A. Mescalchin, M. Rompf, and G. Sczakiel Phosphorothioate-stimulated cellular uptake of siRNA: A cell culture model for mechanistic studies Current Pharmaceutical Design 14 34 2008 3666 3673
8. A. Eguchi, and S.F. Dowdy Efficient siRNA delivery by novel PTD-DRBD fusion proteins Cell Cycle 9 3 2010 424 425
9. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 6836 2001 494 498
10. J. Elmen, H. Thonberg, K. Ljungberg, M. Frieden, M. Westergaard, and Y. Xu Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality Nucleic Acids Research 33 1 2005 439 447
11. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 6669 1998 806 811
12. P.P. Jagodzinski, R. Wiaderkiewicz, G. Kurzawski, M. Kloczewiak, H. Nakashima, and E. Hyjek Mechanism of the inhibitory effect of curdlan sulfate on HIV-1 infection in vitro Virology 202 2 1994 735 745
13. R. Kanasty, J.R. Dorkin, A. Vegas, and D. Anderson Delivery materials for siRNA therapeutics Nature Materials 12 11 2013 967 977
14. L. Li, F.P. Gao, H.B. Tang, Y.G. Bai, R.F. Li, and X.M. Li Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin Nanotechnology 21 26 2010 265601
15. K.T. Love, K.P. Mahon, C.G. Levins, K.A. Whitehead, W. Querbes, and J.R. Dorkin Lipid-like materials for low-dose, in vivo gene silencing Proceedings of the National Academy of Sciences of the United States of America 107 5 2010 1864 1869
16. M. McIntosh, B.A. Stone, and V.A. Stanisich Curdlan and other bacterial (1-3)-beta-d-glucans Applied Microbiology and Biotechnology 68 2 2005 163 173
17. S. Mochizuki, and K. Sakurai Dectin-1 targeting delivery of TNF-alpha antisense ODNs complexed with beta-1,3-glucan protects mice from LPS-induced hepatitis Journal of Controlled Release 151 2 2011 155 161
18. D.V. Morrissey, J.A. Lockridge, L. Shaw, K. Blanchard, K. Jensen, and W. Breen Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs Nature Biotechnology 23 8 2005 1002 1007
19. K. Na, K.H. Park, S.W. Kim, and Y.H. Bae Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2) Journal of Controlled Release 69 2 2000 225 236
20. M. Nakata, T. Kawaguchi, Y. Kodama, and A. Konno Characterization of curdlan in aqueous sodium hydroxide Polymer 39 6-7 1998 1475 1481
21. T.M. Rana Illuminating the silence: understanding the structure and function of small RNAs Nature Reviews Molecular Cell Biology 8 1 2007 23 36
22. H. Rogers, D.W. Williams, G.J. Feng, M.A. Lewis, and X.Q. Wei Role of bacterial lipopolysaccharide in enhancing host immune response to Candida albicans Clinical and Developmental Immunology 2013 2013 320168
23. D.B. Rozema, D.L. Lewis, D.H. Wakefield, S.C. Wong, J.J. Klein, and P.L. Roesch Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes Proceedings of National Academy of Sciences of the United States of America 104 32 2007 12982 12987
24. S.C. Semple, A. Akinc, J. Chen, A.P. Sandhu, B.L. Mui, and C.K. Cho Rational design of cationic lipids for siRNA delivery Nature Biotechnology 28 2 2010 172 176
25. N.M. Snead, J.R. Escamilla-Powers, J.J. Rossi, and A.P. McCaffrey 5' Unlocked nucleic acid modification improves siRNA targeting Molecular Therapy - Nucleic Acids 2 2013 e103
26. J. Soutschek, A. Akinc, B. Bramlage, K. Charisse, R. Constien, and M. Donoghue Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 432 7014 2004 173 178
27. Z. ur Rehman, D. Hoekstra, and I.S. Zuhorn Mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: Real-time visualization of transient membrane destabilization without endosomal lysis ACS Nano 7 5 2013 3767 3777
28. Y. Yang, X. Liu, D. Zhang, W. Yu, G. Lv, and H. Xie Chitosan/VEGF-sIRNA nanoparticle for gene silencing Journal of Controlled Release 152 Suppl 1 2011 e160 e161